Stay updated on FG-3019 for Diabetic Nephropathy Clinical Trial
Sign up to get notified when there's something new on the FG-3019 for Diabetic Nephropathy Clinical Trial page.

Latest updates to the FG-3019 for Diabetic Nephropathy Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedLocations section added with 18 site locations by state (AL, AZ, CA, FL, GA, MA, NE, NY, NC, OH, OR, PA, TX, VA). Footer revision tag updated to v3.3.3.SummaryDifference2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2, likely a template or UI update with no change to study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1, indicating a minor update to the page framework with no changes to study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the banner note about lapse in government funding and NIH operating status that previously appeared on the page. This change affects only an informational banner and does not modify the study data, locations, or eligibility details.SummaryDifference0.4%

- Check63 days agoChange DetectedMinor UI/formatting updates and a timestamp change; core study data such as title, conditions, interventions, eligibility, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check92 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference5%

Stay in the know with updates to FG-3019 for Diabetic Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 for Diabetic Nephropathy Clinical Trial page.